Tzivia Berkman

Tzivia Berkman has extensive work experience in the field of clinical operations and management. They started their career as a Student Intern at Harvard Medical School and Children's Hospital in 2006. After that, Tzivia worked at various pharmaceutical and biotech companies. They served as a Pre-clinical Research Associate at Tiltan Pharma from October 2006 to July 2009. Subsequently, they worked as a Clinical Trial Associate from July 2009 to December 2013 and then as a Senior Manager at Tiltan Pharma from December 2013 to July 2017. In this role, Tzivia was responsible for leading the clinical development and operation of a phase 2 oncology clinical trial, managing pharmacovigilance activities, and overseeing the operations of the trial.

In 2018, Tzivia joined BioSight Ltd. as a Project Manager and was involved in managing projects for the company until February 2019. They then worked at BerGenBio ASA from August 2019 to March 2023 as a Clinical Analyst, contributing to clinical analysis projects.

Currently, Tzivia works at Pangea Biomed since April 2023 as a Clinical Operation Manager, although further details regarding their responsibilities in this role were not provided.

Tzivia Berkman completed their education at The Hebrew University of Jerusalem. From 1999 to 2003, they obtained a B.Sc.Pharm degree from the School of Pharmacy. Following this, they pursued further studies and earned an M.Sc degree in Pharmacology from the same university, completing it between the years 2003 and 2006.

In addition to their academic degrees, Tzivia Berkman has obtained several certifications to enhance their knowledge and skills. In 2018, they completed a course titled "Writing in the Sciences" at Stanford University Coursera. Tzivia also holds certifications in "Good Clinical Practice" from GCP Clinical Studies, obtained in November 2014, and "Designing and Writing Clinical Study Protocols" from Bioforum Ltd., acquired in May 2012.